JP2019528247A5 - - Google Patents

Download PDF

Info

Publication number
JP2019528247A5
JP2019528247A5 JP2019501619A JP2019501619A JP2019528247A5 JP 2019528247 A5 JP2019528247 A5 JP 2019528247A5 JP 2019501619 A JP2019501619 A JP 2019501619A JP 2019501619 A JP2019501619 A JP 2019501619A JP 2019528247 A5 JP2019528247 A5 JP 2019528247A5
Authority
JP
Japan
Prior art keywords
methylquinoxalin
methoxy
thiazol
oxy
carbamate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019501619A
Other languages
English (en)
Japanese (ja)
Other versions
JP7058256B2 (ja
JP2019528247A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/041878 external-priority patent/WO2018013774A1/en
Publication of JP2019528247A publication Critical patent/JP2019528247A/ja
Publication of JP2019528247A5 publication Critical patent/JP2019528247A5/ja
Application granted granted Critical
Publication of JP7058256B2 publication Critical patent/JP7058256B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019501619A 2016-07-14 2017-07-13 二環式ヘテロアリール置換化合物 Active JP7058256B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662362113P 2016-07-14 2016-07-14
US62/362,113 2016-07-14
PCT/US2017/041878 WO2018013774A1 (en) 2016-07-14 2017-07-13 Bicyclic heteroaryl substituted compounds

Publications (3)

Publication Number Publication Date
JP2019528247A JP2019528247A (ja) 2019-10-10
JP2019528247A5 true JP2019528247A5 (OSRAM) 2020-08-13
JP7058256B2 JP7058256B2 (ja) 2022-04-21

Family

ID=59384258

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019501619A Active JP7058256B2 (ja) 2016-07-14 2017-07-13 二環式ヘテロアリール置換化合物

Country Status (7)

Country Link
US (2) US20190292176A1 (OSRAM)
EP (1) EP3484878B1 (OSRAM)
JP (1) JP7058256B2 (OSRAM)
KR (1) KR102460385B1 (OSRAM)
CN (1) CN109689647B (OSRAM)
ES (1) ES2823180T3 (OSRAM)
WO (1) WO2018013774A1 (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2805030T3 (es) 2016-07-14 2021-02-10 Bristol Myers Squibb Co Compuestos monocíclicos sustituidos con heteroarilo
EP3484894B1 (en) 2016-07-14 2020-08-19 Bristol-Myers Squibb Company Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as par4 inhibitors
WO2018013770A1 (en) 2016-07-14 2018-01-18 Bristol-Myers Squibb Company Bicyclic heteroaryl substituted compounds
CN109836360B (zh) * 2019-03-19 2021-08-13 南京恩泰医药科技有限公司 一种甲苯磺酸依度沙班中间体的制备方法及中间体化合物
CN113024475B (zh) * 2019-12-25 2022-08-09 宁夏大学 一种喹喔啉酮类化合物的合成方法
CN111440146B (zh) * 2020-05-15 2022-10-21 中国药科大学 一种具有par4拮抗活性的苯并三嗪类化合物及其应用
JP7753950B2 (ja) * 2022-03-30 2025-10-15 三菱ケミカル株式会社 環状亜硫酸エステルの製造方法
WO2024023012A1 (en) 2022-07-28 2024-02-01 Bayer Aktiengesellschaft Process for preparation of 2-chloro-3-fluoro-4-alkoxy-anilines and 2-fluoro-3-chlorophenol
WO2024131948A1 (zh) * 2022-12-22 2024-06-27 人福医药集团股份公司 制备p2x3抑制剂的方法
CN115925588A (zh) * 2022-12-26 2023-04-07 诚达药业股份有限公司 一种脂肪族亚磺酸钠盐的制备方法
AR131541A1 (es) 2023-01-07 2025-04-09 Syngenta Crop Protection Ag Compuestos de carboxamida novedosos
WO2025032129A1 (en) 2023-08-08 2025-02-13 Syngenta Crop Protection Ag Novel aminoindane and aminotetraline compounds
US11986461B1 (en) 2023-08-24 2024-05-21 King Faisal University 3-(1-(3-(dimethylamino)propyl)-4,5-diphenyl-1H-imidazol-2-yl)pyridin-2-ol as an antitumor and antimicrobial compound
US11976055B1 (en) 2023-08-24 2024-05-07 King Faisal University 2-(1-(3-(dimethylamino)propyl)-4,5-diphenyl-1H-imidazol-2-yl)pyridin-3-ol as an antitumor and antimicrobial compound
US11964959B1 (en) 2023-09-05 2024-04-23 King Faisal University 3-(4,5-Diphenyl-2-(pyridin-3-yl)-1H-imidazol-1-yl)-N,N-dimethylpopan-1-amine as an antimicrobial compound
WO2025109114A1 (en) 2023-11-24 2025-05-30 Syngenta Crop Protection Ag Novel carboxamide compounds
US11952361B1 (en) 2023-12-26 2024-04-09 King Faisal University 2-(1-(3-(dimethylamino)propyl)-4,5-diphenyl-1H-imidazol-2-yl) pyridin-3-ol as an antitumor and antimicrobial compound
WO2025149629A1 (en) 2024-01-12 2025-07-17 Syngenta Crop Protection Ag Novel carboxamide compounds
WO2025149637A1 (en) 2024-01-12 2025-07-17 Syngenta Crop Protection Ag Novel carboxamide compounds

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1164459A (en) * 1980-11-11 1984-03-27 Yung-Hsiung Yang Process for preparing (imidazo¬1,2-a|pyridine- 2-yl)-carbostyril or -3,4-dihydrocarbostyryl derivatives
SU1681729A3 (ru) * 1986-07-25 1991-09-30 Берингер Ингельгейм Кг (Фирма) Способ получени производных 1,4-бензодиазепина
TW279162B (OSRAM) * 1991-09-26 1996-06-21 Mitsubishi Chem Corp
JP2928079B2 (ja) 1994-02-14 1999-07-28 永信薬品工業股▲ふん▼有限公司 1−(置換ベンジル)−3−(置換アリール)縮合ピラゾール類、その製造法及びその用途
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
ATE246184T1 (de) * 1996-11-06 2003-08-15 Darwin Discovery Ltd Chinoline und deren therapeutische verwendung
US6313126B1 (en) * 1999-01-07 2001-11-06 American Home Products Corp Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
US6387942B2 (en) 2000-06-19 2002-05-14 Yung Shin Pharmaceutical Ind. Co. Ltd Method of treating disorders related to protease-activated receptors-induced cell activation
EP1348701A1 (en) 2002-03-28 2003-10-01 Warner-Lambert Company LLC (2,4-disubstituted-thiazol-5-yl) amine compounds as PDE7 inhibitors
ZA200600424B (en) 2003-08-01 2007-05-30 Genelabs Tech Inc Bicyclic imidazol derivatives against flaviviridae
WO2005113522A1 (en) 2004-05-07 2005-12-01 Janssen Pharmaceutica, N.V. Azole carboxamide inhibitors of bacterial type iii protein secretion systems
AU2005267798A1 (en) 2004-07-28 2006-02-09 Irm Llc Compounds and compositions as modulators of steroid hormone nuclear receptors
MX2007008587A (es) 2005-01-14 2007-09-07 Genelabs Tech Inc Derivados de indol para tratamiento de infecciones virales.
US20080015193A1 (en) 2006-06-20 2008-01-17 Mendoza Jose S Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof
MX2008015923A (es) 2006-06-29 2009-01-13 Hoffmann La Roche Derivados de bencimidazol, metodo para su produccion, su uso como agonistas fxr y preparaciones farmaceuticas que los contienen.
WO2008073451A2 (en) 2006-12-11 2008-06-19 Sirtris Pharmaceuticals, Inc. Benzoimidazole derivatives as sirtuin (sir) modulating compounds
WO2009073497A2 (en) 2007-11-30 2009-06-11 Smithkline Beecham Corporation Prolyl hydroxylase inhibitors
CA2723135A1 (en) 2008-05-01 2009-11-05 Sirtris Pharmaceuticals, Inc. Quenolines and related analogs as sirtuin modulators
KR101257158B1 (ko) 2008-05-23 2013-04-23 노파르티스 아게 단백질 티로신 키나제 억제제로서의 퀴놀린 및 퀴녹살린의 유도체
WO2010011768A1 (en) 2008-07-23 2010-01-28 Vertex Pharmaceuticals Incorporated Tri-cyclic pyrazolopyridine kinase inhibitors
TW201018682A (en) * 2008-09-25 2010-05-16 Kyorin Seiyaku Kk Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient
US20130072473A1 (en) 2011-05-09 2013-03-21 Proteostasis Therapeutics, Inc. Compounds for treating protein folding disorders
TW201348226A (zh) 2012-02-28 2013-12-01 Amgen Inc 作為pim抑制劑之醯胺
JP6181744B2 (ja) 2012-04-26 2017-08-16 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company 血小板凝集を治療するためのプロテアーゼ活性化受容体4(par4)阻害剤としてのイミダゾチアジアゾール誘導体
JP6101343B2 (ja) 2012-04-26 2017-03-22 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company 血小板凝集を治療するためのプロテアーゼ活性化受容体4(par4)阻害剤としてのイミダゾチアジアゾールおよびイミダゾピリダジン誘導体
HUE060743T2 (hu) 2012-04-26 2023-04-28 Bristol Myers Squibb Co Gyógyszerészeti kompozíciók, amelyek tartalmaznak imidazothiadiazol- és imidazopiridazinszármazékokat mint proteáz aktívált receptor 4 (PAR4) inhibitorokat trombocitaaggregációk kezelésére
US9617279B1 (en) 2014-06-24 2017-04-11 Bristol-Myers Squibb Company Imidazooxadiazole compounds
US9598419B1 (en) 2014-06-24 2017-03-21 Universite De Montreal Imidazotriazine and imidazodiazine compounds
WO2016134450A1 (en) 2015-02-26 2016-09-01 Université de Montréal Imidazopyridazine and imidazothiadiazole compounds
EP3262052A1 (en) 2015-02-26 2018-01-03 Bristol-Myers Squibb Company Benzothiazole and benzothiophne compounds
AU2016261031A1 (en) * 2015-05-13 2017-10-05 Selvita S.A. Substituted quinoxaline derivatives
CN108137514A (zh) 2015-07-30 2018-06-08 百时美施贵宝公司 芳基取代的二环杂芳基化合物
WO2018013770A1 (en) 2016-07-14 2018-01-18 Bristol-Myers Squibb Company Bicyclic heteroaryl substituted compounds
ES2805030T3 (es) 2016-07-14 2021-02-10 Bristol Myers Squibb Co Compuestos monocíclicos sustituidos con heteroarilo
EP3484894B1 (en) 2016-07-14 2020-08-19 Bristol-Myers Squibb Company Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as par4 inhibitors

Similar Documents

Publication Publication Date Title
JP2019528247A5 (OSRAM)
JP7126541B2 (ja) ハンチントンタンパク質のイメージング用プローブ
CN104583218B (zh) 作为蛋白酶活化受体4(par4)抑制剂用于治疗血小板聚集的咪唑并噻二唑和咪唑并吡嗪的衍生物
JP7440101B2 (ja) キナーゼ阻害剤としてのヘテロ環式化合物、ヘテロ環式化合物を含む組成物、及びそれらを使用する方法
ES2823180T3 (es) Compuestos bicíclicos sustituidos con heteroarilo
JP7001682B2 (ja) 置換1H-イミダゾ[4,5-b]ピリジン-2(3H)-オン及びGLUN2B受容体調節因子としてのそれらの使用
JP2020527560A5 (OSRAM)
CN111032656A (zh) 杂环化合物激酶抑制剂及其药物组合物和应用
AU2005289644A1 (en) Imidazo{4,5-b}pyrazinone inhibitors of protein kinases
RU2010134900A (ru) 5-фторпиримидиновые производные в качестве фунгицидов
JP2016500073A5 (OSRAM)
JP2017526622A (ja) 3−アミノ−1,5,6,7−テトラヒドロ−4h−インドール−4−オン類
CA2971357A1 (en) Amido thiadiazole derivatives as nadph oxidase inhibitors
CA2897469A1 (en) Pyridine derivatives as muscarinic m1 receptor positive allosteric modulators
CN104125947A (zh) 杂环脲化合物
TW202434584A (zh) Gpr17調節劑及其用途
KR102390234B1 (ko) 트리시클릭 피페리딘 화합물
WO2012064269A1 (en) COMPOUNDS AND THEIR USE FOR TREATMENT OF Αβ-RELATED DISEASES
JP2019524732A5 (OSRAM)
WO2009128661A2 (ko) 신규 벤조옥사진 벤즈이미다졸 유도체, 이를 포함하는 약학 조성물 및 이의 용도
AU2015212495A1 (en) Antibacterial combinations comprising polymyxin
WO2024095005A1 (en) Diaryl diazole and diaryl triazole derivatives for use in treating a disease associated with kcnk13 activity
RU2025114402A (ru) Получение производных пиразолопиридина и триазолопиридина в качестве новых ингибиторов диацилглицерид о-ацилтрансферазы 2